Clinical Study

Serum Bone Resorption Markers after Parathyroidectomy for Renal Hyperparathyroidism: Correlation Analyses for the Cross-Linked N-telopeptide of Collagen I and Tartrate-Resistant Acid Phosphatase

Table 1

Clinical variables and biochemical parameters for the control group and for the parathyroidectomy (PTX) group before and 4 weeks after the surgery.

PTX ( 𝑛 = 2 3 )Control ( 𝑛 = 2 5 )

Age, y49.3 ± 10.849.6 ± 11.4
Gender (M/F)11/1212/13
HD duration70.1 ± 21.9 months68.7 ± 19.3 months
1,25(OH)2 vitamin D32.0 μg/day(—)

D0W4D0W4

iPTH, pg/mL1293.3 ± 591.9b38.2 ± 23.6d189.4 ± 75.2f192.4 ± 87.4f
NTX, (nM BCE/L)1227.3 ± 458.8a679.1 ± 307.2d784.1 ± 325.6769.4 ± 319.6e
TRAP, U/L8.87 ± 5.27b2.81 ± 0.61d2.24 ± 0.65f2.19 ± 0.67f
BAP, U/L158.6 ± 71.2b152.6 ± 53.6d26.5 ± 8.4f27.4 ± 9.1f
TCa, mg/dL10.89 ± 0.86b8.52 ± 0.54c9.5 ± 0.6e9.6 ± 0.6f
Pi, mg/dL6.10 ± 0.48a2.95 ± 0.77d4.9 ± 0.5f5.0 ± 0.6f
Albumin, g/dL3.91 ± 0.363.98 ± 0.333.95 ± 0.373.96 ± 0.36
FC, %
 iPTH−96.92 ± 1.901.58 ± 16.22
 NTX−44.43 ± 11.023.40 ± 8.33
 TRAP−61.76 ± 13.84−2.23 ± 3.08
 BAP−0.75 ± 17.04−1.87 ± 1.84

a 𝑃 < 0 . 0 5 , b 𝑃 < 0 . 0 1 , compared with control group at D0; c 𝑃 < 0 . 0 5 , d 𝑃 < 0 . 0 1 , compared with PTX group at D0; e 𝑃 < 0 . 0 5 , f 𝑃 < 0 . 0 1 , compared with PTX group at W4, Abbreviations: BCE, bone collagen equivalents; BAP, bone alkaline phosphatase; D0, Day 0, before performance of PTX; HD, hemodialysis; W4, 4 weeks after PTX; iPTH, intact parathyroid hormone; NTX, cross-linked N-telopeptide of type I collagen; PTX, parathyroidectomy; Pi, inorganic phosphate; TCa, total calcium; TRAP, tartrate-resistant acid phosphatase 5b; FC: fractional change (%) in marker value between D0 and W4.